about
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mec...
Read More
2.25
0.12
(5.63%)
28,045
XNAS Volume
XNAS 01 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
NuCana PLC (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..